Archive
The panel discussion on Overseas Listing – Insights for Corporates took place on Monday, 23 November 2020. The second conversation of the webinar series was focused on high-growth mid-market companies that have explored the overseas listing opportunity or are interested in knowing more about overseas listing.
Key Highlights
- Companies with global aspirations and well-defined strategies for growth should consider listing overseas. Healthcare, pharma, cleantech and biotech companies will be among the early drivers of overseas listing.
- Understanding the process and choosing the right partners is key to achieving a successful listing. Advisors provide the right direction in terms of roadshows, due diligence checks and regulatory compliances.
- While overseas listing provides flexibility, there are strict governance and compliance requirements to be adhered to.
- Knowing your investors and the market for your business are crucial factors for choosing the exchange for listing.
Speakers
 |
 |
 |
 |
 |
| Vishesh C. Chandiok CEO Grant Thornton Bharat |
Keshav R. Murugesh (keynote) Group CEO WNS Global Services, Past Chairman, NASSCOM |
Robert H. McCooey, Jr. Chairman, Asia Pacific NASDAQ |
Gokul Mani Head of Primary Markets – Middle East, Africa & India London Stock Exchange (LSE) |
Bharat K. Reddy JPMorgan Chase & Co. |
 |
 |
 |
 |
 |
| Francis Giglio MD & Head, Depositary Receipts – APAC, Hong Kong BNY Mellon |
Rajiv Gupta Partner Latham & Watkins LLP, Singapore |
Sanjay Banthia Chartered Accountant, Mumbai |
Raja Lahiri Partner Grant Thornton Bharat |
Prashant Mehra (moderator) Partner Grant Thornton Bharat |
If you are interested in exploring the overseas listing opportunity for your organisation, or have any questions, please email our expert at Raja.Lahiri@IN.GT.COM
Date & Time
Date: Friday 06 November, 2020
Time: 17:00 - 19:00 Hrs IST